Skip to content

Dr. Bart: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

Dr. Bart

BE 1004.023.937
NACE 86.210, General medical practice
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€67,736
2024 · €91,152-€23,416
Equity
€168,888
2024 · €101,152+€67,736
Cash
€99,839
2024 · €60,797+€39,042
Balance sheet total
€183,890
2024 · €134,516+€49,373

Largest movements

2024 to 2025
Assets
  • Cash +€39,042

    up €39,042 (+64.2%), from €60,797 to €99,839

    mainly Net result for the year (+€67,736) and Trade debts (+€9,140)

  • Receivables within one year +€9,093

    up €9,093 (+16.2%), from €56,277 to €65,370

    of which Other amounts receivable: +€6,665

Equity and liabilities
  • Profit (loss) carried forward +€67,736

    up €67,736 (+74.3%), from €91,152 to €158,888

  • Tax, wage and social debts -€27,502

    down €27,502 (-100.0%), from €27,502 to €0

  • Trade debts +€9,140

    up €9,140 (+155.9%), from €5,862 to €15,002

Income statement
  • Gross operating margin -€31,820

    down €31,820 (-26.4%), from €120,561 to €88,741

  • Taxes -€7,079

    down €7,079 (-25.7%), from €27,502 to €20,424

  • Other operating charges -€1,252

    down €1,252 (-70.4%), from €1,780 to €528

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €91,152
Gross operating margin -€31,820
Other operating charges +€1,252
Financial income -€1
Financial charges +€74
Taxes +€7,079
Result 2025 €67,736

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€39,042
Investment €0
Financing €0
Cash 2024 €60,797
Net result for the year +€67,736
Receivables within one year -€9,093
Deferred charges and accrued income -€1,238
Trade debts +€9,140
Tax, wage and social debts -€27,502
Cash 2025 €99,839
Every line side by side 28 lines
Line Code 2024 2025 Change %
Total assets 20/58 €134,516 €183,890 +€49,373 +36.7%
Current assets 29/58 €134,516 €183,890 +€49,373 +36.7%
Amounts receivable within one year 40/41 €56,277 €65,370 +€9,093 +16.2%
Trade receivables 40 - €2,428 +€2,428
Other amounts receivable 41 €56,277 €62,942 +€6,665 +11.8%
Cash at bank and in hand 54/58 €60,797 €99,839 +€39,042 +64.2%
Deferred charges and accrued income 490/1 €17,442 €18,681 +€1,238 +7.1%
Total equity and liabilities 10/49 €134,516 €183,890 +€49,373 +36.7%
Equity 10/15 €101,152 €168,888 +€67,736 +67.0%
Contributions 10/11 €10,000 €10,000 = 0.0%
Profit (loss) carried forward 14 €91,152 €158,888 +€67,736 +74.3%
Amounts payable 17/49 €33,364 €15,002 -€18,362 -55.0%
Amounts payable within one year 42/48 €33,364 €15,002 -€18,362 -55.0%
Trade debts 44 €5,862 €15,002 +€9,140 +155.9%
Suppliers 440/4 €5,862 €15,002 +€9,140 +155.9%
Taxes, remuneration and social security 45 €27,502 €0 -€27,502 -100.0%
Taxes 450/3 €27,502 €0 -€27,502 -100.0%
Other operating charges 640/8 €1,780 €528 -€1,252 -70.4%
Gross operating margin 9900 €120,561 €88,741 -€31,820 -26.4%
Operating profit (loss) 9901 €118,781 €88,213 -€30,568 -25.7%
Financial income 75/76B €1 €0 -€1 -100.0%
Recurring financial income 75 €1 €0 -€1 -100.0%
Financial charges 65/66B €128 €54 -€74 -57.7%
Recurring financial charges 65 €128 €54 -€74 -57.7%
Profit (loss) for the period before taxes 9903 €118,654 €88,159 -€30,495 -25.7%
Income taxes 67/77 €27,502 €20,424 -€7,079 -25.7%
Profit (loss) for the period 9904 €91,152 €67,736 -€23,416 -25.7%
Profit (loss) for the period to be appropriated 9905 €91,152 €67,736 -€23,416 -25.7%

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 4 October 2026 via checked.be.